| Ex. AGY-FED-HEALTH-OTHER-118 | Provider Relief Fund, Acceptance of Terms and Conditions, Relief Fund Payment from Initial $30 Billion General DistributionAcceptance of Terms and Conditions - Relief Fund Payment from Initial $30 Billion General Distribution | Secretary of Health and Human Services (terms administered by HRSA) | United States (federal); Department of Health and Human Services (Health Resources and Services Administration administering the Provider Relief Fund)Federal | Apr. 10, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-019 | DEA-DC-029 (DEA085), letter granting a temporary exception to the five percent rule for practitioners distributing controlled substances to other registrants during the COVID-19 emergencyDEA 5 percent practitioner exception (final) | William T. McDermott, Assistant Administrator, Diversion Control Division, DEA | United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal | Apr. 13, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersSupply chainOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-020 | DEA-DC-030 (DEA087), letter extending the off-site take-home delivery flexibility to buprenorphine dispensed by opioid treatment programsOff site OTP delivery buprenorphine | Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA | United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal | Apr. 21, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-025 | FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergencyFAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency | SAMHSA, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies | United States (federal); Department of Health and Human Services, Substance Abuse and Mental Health Services AdministrationFederal | Apr. 21, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Context (guidance or announcement)Health care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-033 | Notice, Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability, 85 Fed. Reg. 27987 (May 12, 2020)Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability | Food and Drug Administration, HHS | United States (federal); Food and Drug AdministrationFederal | May 12, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersSupply chainOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-077 | COVID-19 Action Plan: Phase Seven (ordered May 18, 2020): all Phase Six measures extended through June 30, 2020COVID-19 Action Plan: Phase Seven - Agency-wide measures extended | Director, Federal Bureau of Prisons | United States (federal); Federal Bureau of PrisonsFederal | May 20, 2020 | 2020 Q2 | Business closureGathering capTravel and quarantineQuarantine and isolation | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-054 | Emergency Use Authorization: Gowns and Other Apparel (umbrella) (May 22, 2020)Letter of Authorization, Gowns and Other Apparel | Denise M. Hinton, Chief Scientist, FDA | United States (federal); Food and Drug AdministrationFederal | May 22, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersSupply chain | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-063 | Interim Final Rule, Informed Consent and Advance Directives, 85 Fed. Reg. 31698 (May 27, 2020)Informed Consent and Advance Directives | Department of Veterans Affairs | United States (federal); Department of Veterans AffairsFederal | May 27, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Telework mandateHealth care orders | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-035 | Notice, Process for Publishing Emergency Use Authorizations for Medical Devices During Coronavirus Disease 2019, 85 Fed. Reg. 33686 (June 2, 2020)Process for Publishing Emergency Use Authorizations for Medical Devices During Coronavirus Disease 2019 | Food and Drug Administration, HHS | United States (federal); Food and Drug AdministrationFederal | June 2, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Other | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-034 | Notice, Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability, 85 Fed. Reg. 34638 (June 5, 2020)Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability | Food and Drug Administration, HHS | United States (federal); Food and Drug AdministrationFederal | June 5, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersSupply chain | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-062 | Interim Final Rule, Home Visits in Program of Comprehensive Assistance for Family Caregivers During COVID-19 National Emergency, 85 Fed. Reg. 34523 (June 5, 2020)Home Visits in Program of Comprehensive Assistance for Family Caregivers During COVID-19 National Emergency | Department of Veterans Affairs | United States (federal); Department of Veterans AffairsFederal | June 5, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Telework mandateHealth care orders | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-071 | Final Rule, Video Visiting and Telephone Calls Under the Coronavirus Aid, Relief, and Economic Security (CARES) Act, 85 Fed. Reg. 37331 (June 22, 2020)Video Visiting and Telephone Calls Under the Coronavirus Aid, Relief, and Economic Security (CARES) Act | Bureau of Prisons, Department of Justice (Michael Carvajal, Director) | United States (federal); Department of Justice, Federal Bureau of PrisonsFederal | June 22, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Gathering capOther | Primary source read | |